Eat out at restaurants and still lose weight

Would you stop eating out to lose weight? — A study reveals that you don’t have to – Going out to eat has become a major part of our culture. Frequently eating out and consuming high-calorie foods in large portions at restaurants can contribute to excess calorie intake and weight gain. However, a study in the Journal of Nutrition Education and Behavior demonstrates that individuals can eat out and still lose weight.

Novartis drug Afinitor everolimus helps advanced breast cancer women

Novartis drug Afinitor? helps women with advanced breast cancer live significantly longer without their disease progressing – A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.

Pfizer new drug could provide a new treatment option for postmenopausal women

Pfizer new drug BZA/CE could provide a new treatment option for symptomatic postmenopausal women with a uterus – Pfizer Inc. will announce new one-year results from the Selective estrogens, Menopause, And Response to Therapy [SMART]-5 Phase 3 study of the safety and efficacy of the investigational tissue selective estrogen complex (TSEC) bazedoxifene/conjugated estrogens (BZA/CE) at the 22nd annual meeting of the North American Menopause Society (NAMS), September_21-24 in Washington, D.C.

Remicade infliximab approved to treat ulcerative colitis in children

FDA approves Remicade to treat ulcerative colitis in children older than 6 years – The U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

Scorpion stings treatment Anascorp approved in US

FDA approves the first specific treatment for scorpion stings – The U.S. Food and Drug Administration approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.

Marked reduction of HIV among circumcised adult men

First global study of real-world circumcision rollout conducted over 3-year period in South Africa amongst 110,000 adults shows a marked reduction (>60 percent) of HIV acquisition among circumcised adult men – Researchers presenting late breaking research on the final day of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have focussed on new studies in the field of circumcision, pre-exposure prophylaxis (PrEP) and antiretroviral treatment. The IAS 2011 conference has been attended by over 5000 researchers, clinicians and community leaders since Sunday in Rome.

Therapy reduces early menopause for women with breast cancer

Therapy appears to reduce rate of chemotherapy-induced early menopause for women with breast cancer – Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.

Copper reduces infection risk by 40%

Copper reduces infection risk by more than 40 percent – Copper touch surfaces could have a key role in preventing the transmission of healthcare-associated infections. Extensive laboratory tests have demonstrated copper’s antimicrobial efficacy against key organisms. A 97% reduction in surface pathogens in rooms with copper surfaces has been demonstrated.

Lithium may prevent brain damage in patients with Parkinson’s disease

Lithium profoundly prevents brain damage associated with Parkinson’s disease — Buck Institute research in mice moves into preclinical stage; working toward human trials – Researcher are focusing on lithium as a potential treatment for Parkinson’s disease — PD — as well as its efficacy in combination with drugs currently used to control the symptoms of the disease. Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson’s disease (PD) in a mouse model of the condition.

2 types of botulinum toxin compared for cosmetic use

Study compares 2 types of botulinum toxin for cosmetic use – Botulinum toxin, a protein long considered harmful, is now known as a neuromodulator (a chemical that affects nerve impulses) that has cosmetic and medical uses. Not all varieties of botulinum toxin seem to be equally effective in reducing crow’s feet wrinkles, according to a report published by Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.